Previous 10 | Next 10 |
2023-10-16 14:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The ClearBridge Multi ...
2023-10-16 05:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Mid cap stocks decline...
2023-10-07 06:00:00 ET This year's stock market rally has left some potential winners behind, and that represents great opportunity for you to buy them for a bargain. Of course, it's not always easy to get excited about stocks that have declined. But it's important to set aside the recent s...
2023-09-25 07:15:00 ET Having been a publicly traded corporation for two years, Doximity (NYSE: DOCS) -- an online networking platform for medical professionals -- hasn't delivered great returns in this period, far from it. And nothing has improved this year, even as the broader sto...
2023-09-24 05:47:00 ET So far in 2023, the S&P 500 and Nasdaq Composite indexes have posted stellar total returns of 16% and 30%, respectively. However, much of these returns have come from the mega-cap MANAMANA stocks , which have risen between 31% and 189% this yea...
2023-09-23 06:15:40 ET Summary Talkspace is reporting strong growth across its online mental health treatment platform. Management expects the company to reach breakeven adjusted EBITDA by Q1 2024. We expect shares to remain volatile but see significant upside potential if the...
2023-08-24 08:30:00 ET Doximity (NYSE: DOCS) operates a networking platform for doctors that claims to have 80% of U.S. physicians on it. It's an impressive statistic, but that hasn't been enough of a reason for investors continue buying up the stock this year. While other growth st...
2023-08-24 00:13:11 ET Summary Doximity's revenue growth and EBITDA exceeded estimates but lowered revenue growth guidance. I downgraded DOCS stock rating to hold due to near-term performance concerns. I still maintain a positive long-term outlook that the business can reach $...
NEW YORK, NY / ACCESSWIRE / August 16, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS). Investors who purchased Doximity securities are encouraged to obtain additional information ...
2023-08-16 10:15:00 ET The past three years have been a roller-coaster ride for investors, and such heightened volatility can sometimes make it hard to focus on the long term. But that is precisely the right move. If history is any indication, equity markets will be up substantially from th...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...